Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SNBL USA Appoints Field Technical Director | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

SNBL USA Appoints Field Technical Director

Templin to provide scientific, regulatory guidance for preclinical programs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Michael Templin, Ph.D., DABT, has been named field technical director for SNBL USA.  Dr. Templin, based on the west coast, will work closely with business development and internal scientific teams to provide SNBL USA’s clients with scientific and regulatory guidance to support their preclinical development programs. He joins the company from Marina Biotech where he served as chief technology officer.
 
Dr. Templin is a board-certified toxicologist with more than 15 years of experience in preclinical and early clinical drug development. He has extensive experience in small molecules, biologics, peptides and multiple classes of nucleic acid-based drugs, and has worked in multiple therapeutic areas including cancer, inflammation, cardiovascular, metabolic and antivirals. He also has experience with nonhuman primate programs, including design, oversight and interpretation of research and GLP studies for INDs, NDAs and ex-U.S. submissions.
 
“This is an exciting time for SNBL USA and our clients,” said Mark Crane, vice president of business development. “Dr. Templin’s exceptional preclinical and early clinical background, along with his technical expertise and outstanding communication skills, will significantly enhance the benefits in working with SNBL USA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics